Cargando…
Mammographic screening detects low-risk tumor biology breast cancers
Overdiagnosis of breast cancer, i.e. the detection of slow-growing tumors that would never have caused symptoms or death, became more prevalent with the implementation of population-based screening. Only rough estimates have been made of the proportion of patients that are overdiagnosed and identifi...
Autores principales: | Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924026/ https://www.ncbi.nlm.nih.gov/pubmed/24469641 http://dx.doi.org/10.1007/s10549-013-2830-5 |
Ejemplares similares
-
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance
por: Viale, Giuseppe, et al.
Publicado: (2016) -
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
por: Drukker, C. A., et al.
Publicado: (2014) -
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
por: Obdeijn, Inge-Marie, et al.
Publicado: (2020) -
Long-term impact of the 70-gene signature on breast cancer outcome
por: Drukker, C. A., et al.
Publicado: (2014) -
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants
por: Evans, D. Gareth R., et al.
Publicado: (2019)